David Lebowitz
Stock Analyst at Citigroup
Total Price Targets
11
Stocks Covered
6
Sectors
Healthcare
Most Recent
Oct 30, 2024
Stocks Covered by David Lebowitz
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | $81.00 | $55.30 | +46.5% | 2 | Oct 30, 2024 |
| EXEL | Exelixis, Inc. | $38.00 | $52.33 | -27.4% | 3 | Oct 30, 2024 |
| INCY | Incyte Corporation | $97.00 | $99.97 | -3.0% | 2 | Oct 30, 2024 |
| BBIO | BridgeBio Pharma, Inc. | $45.00 | $66.88 | -32.7% | 1 | Oct 24, 2024 |
| COGT | Cogent Biosciences, Inc. | $15.00 | $33.40 | -55.1% | 2 | Sep 24, 2024 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $27.00 | $76.48 | -64.7% | 1 | Sep 3, 2024 |
Recent Activity
- Oct 30, 2024— Set$38.00price target onEXEL(Exelixis, Inc.)
- Oct 30, 2024— Set$97.00price target onINCY(Incyte Corporation)
- Oct 30, 2024— Set$81.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Oct 24, 2024— Set$45.00price target onBBIO(BridgeBio Pharma, Inc.)
- Sep 24, 2024— Set$15.00price target onCOGT(Cogent Biosciences, Inc.)
- Sep 18, 2024— Set$93.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Sep 16, 2024— Set$31.00price target onEXEL(Exelixis, Inc.)
- Sep 3, 2024— Set$27.00price target onARWR(Arrowhead Pharmaceuticals, Inc.)
- Sep 3, 2024— Set$13.00price target onCOGT(Cogent Biosciences, Inc.)
- Aug 18, 2024— Set$92.00price target onINCY(Incyte Corporation)
- May 20, 2024— Set$31.00price target onEXEL(Exelixis, Inc.)
Frequently Asked Questions
Who is David Lebowitz?
David Lebowitz is a stock analyst at Citigroup covering 6 stocks primarily in Healthcare. They have issued 11 price targets since May 20, 2024.
What stocks does David Lebowitz cover?
David Lebowitz currently covers 6 stocks, including EXEL, BMRN, INCY, COGT, BBIO.
What is David Lebowitz's latest price target?
David Lebowitz's most recent price target was $38.00 on EXEL (Exelixis, Inc.), set on Oct 30, 2024.
What is David Lebowitz's highest price target?
David Lebowitz's highest issued price target is $97.00 on INCY, set on Oct 30, 2024.
More Analysts at Citigroup
Coverage based on publicly published price targets. Not investment advice.